Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,581.00
(
1.15%
)
US TECH 100
23,567.20
(
1.22%
)
Dow Jones
46,208.47
(
1.38%
)
Brent Oil
99.91
(
3.22%
)
Bitcoin
70,615.00
(
-0.40%
)
News Focus
News Focus
Post# of 30495
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122807
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 22579

Wednesday, 10/21/2020 9:55:10 AM

Wednesday, October 21, 2020 9:55:10 AM

Post# of 30495
ABT 3Q20 Results by Business Segment 
 
                  %Corp      YoY Growth  
 Segment          Sales   (const currency)  
 Medical devices*  36%        +3%  
 Diagnostics       30%       +39%  
 Nutrition         22%        +4%  
 Drugs†            12%        -3%
COVID-19 testing boosted the diagnostics segment, while the medical-devices segment bounced back from a COVID-related dip in 2Q20.

62% of overall sales were ex-US.

*Includes diabetes care.
†Branded generics in emerging markets.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today